MarginsXMarginsX
Home › Canada › CSE stocks › CDVA

CordovaCann Corp. (CSE: CDVA)

CDVA trades on the Canadian Securities Exchange in Life Sciences, headquartered in Ontario. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.

Close · November 13, 2026
C$0.0100
0.00% on the day
Market cap (C$)
No market cap: no shares figure public yet
Market cap (US$)
No C$ cap to convert
1-year return
-75.0%
-66.7% year to date

Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of November 13, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for CDVA.CN, last bar 2026-11-13, computed by MarginsX.

Profile

FieldValue
TickerCDVA on the Canadian Securities Exchange
Yahoo symbolCDVA.CN
SectorLife Sciences, Drug Manufacturers—Specialty & Generic
HeadquartersOntario
ListedThe TMX list gives no listing date
Listing typeTMX leaves listing type blank for long-listed issuers
Shares outstandingNot on the TMX list
Also listed onNo interlisting on the TMX list
Index membershipNot in an S&P/TSX index per the TMX list
SEC CIK0001168981
WebsiteNo company website on record

Returns

WindowReturn
1 day0.0%
1 week-60.0%
1 month-60.0%
3 months-60.0%
6 months-50.0%
Year to date-66.7%
1 year-75.0%
From 52-week high-87.5%
52-week rangeC$0.0100 to C$0.0800

Links

SEDAR+ is linked for searching only; nothing on this page is taken from it.

Recent Canadian filings by type

73 documents in 6 types. Each title links to the document at its source.

MD&A (18)

DocumentTypeFiled
Interim Financial Statements and MD&A for the period ended March 31, 2024
Period 2024-03-31
MD&A (interim) (6-K)2026-09-21
Interim Financial Statements and MD&A for the period ended December 31, 2023
Period 2023-12-31
MD&A (interim) (6-K)2026-09-21
Interim Financial Statements and MD&A for the period ended September 30, 2023
Period 2023-09-30
MD&A (interim) (6-K)2026-09-21
Interim Financial Statements and MD&A for the period ended March 31, 2023
Period 2023-03-31
MD&A (interim) (6-K)2026-09-21

Material change report (2)

DocumentTypeFiled
MATERIAL CHANGE REPORTMaterial change report (6-K)2026-09-21
MATERIAL CHANGE REPORTMaterial change report (6-K)2026-09-21

News release (23)

DocumentTypeFiled
NEWS RELEASENews release (6-K)2026-09-21
NEWS RELEASENews release (6-K)2026-09-21
NEWS RELEASENews release (6-K)2026-09-21
NEWS RELEASENews release (6-K)2026-09-21

Annual report (3)

DocumentTypeFiled
FORM 20-F
Period 2025-06-30
Annual report (20-F) (20-F)2026-02-02
FORM 20-F/A
Period 2024-06-30
Annual report (20-F) (20-F/A)2025-04-28
FORM 20-F
Period 2024-06-30
Annual report (20-F) (20-F)2024-12-16

Certification (9)

DocumentTypeFiled
CERTIFICATION
Period 2025-06-30
Certification (SOX 302/906) (20-F)2026-02-02
CERTIFICATION
Period 2025-06-30
Certification (SOX 302/906) (20-F)2026-02-02
CERTIFICATION
Period 2025-06-30
Certification (SOX 302/906) (20-F)2026-02-02
CEO
Period 2024-06-30
Certification (SOX 302/906) (20-F/A)2025-04-28

Other (18)

DocumentTypeFiled
CONSENT DNTW
Period 2025-06-30
Consent (20-F)2026-02-02
CONSENT
Period 2025-06-30
Consent (20-F)2026-02-02
CONSENT DNTW TORONTO LLP
Period 2024-06-30
Consent (20-F/A)2025-04-28
CONSENT KRESTON GTA LLP
Period 2024-06-30
Consent (20-F/A)2025-04-28

Sources: SEC EDGAR filings (public records). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.

Trading halts

No CIRO halt notices for this company in our data.

Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.

Upcoming events

No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.

Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.

US private placements (SEC Form D)

FiledSecuritiesSoldOfferedFiling
2022-04-21Equity, Option To Acquire, Security To Be Acquired, OtherUS$1.7MUS$3.3MSEC EDGAR
2021-08-31Equity, Option To Acquire, Security To Be Acquired, OtherUS$524KUS$1.3MSEC EDGAR
2021-04-01EquityUS$1.1MUS$1.1MSEC EDGAR
2021-03-16Equity, OtherUS$1.4MUS$1.4MSEC EDGAR
2020-09-02Equity, OtherUS$502KUS$502KSEC EDGAR

Source: SEC EDGAR Form D filings matched on SEC CIK. Amounts are US$ as filed.

Peers in Life Sciences

TickerCompanyExchangeMarket cap (C$)1 month1 year
NAVNAVCO Pharmaceuticals Inc.TSXVC$285K0.0%0.0%
EVMTEvome Medical Technologies Inc.TSXVC$301K0.0%0.0%
ARCARCpoint Inc.TSXVC$332K0.0%0.0%
VXLVaxil Bio Ltd.TSXVC$398K-24.1%-35.3%
WAVEWaverley Pharma Inc.TSXVC$540K+100.0%0.0%

The app has the price chart, every filing, private raises and the full peer set for CDVA.

Open in the app